Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 3-step cabazitaxel synthesis from 7,10-dimethoxy-10-deacetylbaccatin III. High purity, mild conditions, scalable for pharmaceutical intermediates supply.
Novel side-chain first coupling strategy for Somaglutide reduces racemization and enhances yield for industrial scale-up.
Advanced preparation method for high-purity Imatinib exceeding 99.5% purity. Optimized solvent recycling and mild conditions ensure cost reduction in pharmaceutical manufacturing.
Novel bicarbonate-mediated carbamate formation for Capecitabine. High yield, simplified purification, cost-effective API intermediate manufacturing.
Novel synthesis of Fasudil Hydrochloride hemihydrate avoiding column chromatography. High purity >99.9% suitable for industrial scale-up and cost reduction.
Advanced purification of 3-hydroxyamidinophenylalanine derivatives using aromatic sulfonic acids. Enhances yield and purity for pharmaceutical manufacturing.
Patent CN106478751B details a pyridine-free route for capecitabine intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN109180577B introduces a superior Aripiprazole synthesis minimizing dimer impurities. Discover cost-effective manufacturing strategies for reliable API intermediate supply.
Patent CN1594287A details a low-pressure condensation route for cytosine precursors, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Discover the enzymatic synthesis route for Nilaparib intermediates described in CN111072550A. Achieve high purity and cost efficiency in API manufacturing with our advanced catalytic technologies.
Advanced purification technology for Gefitinib via salt-forming and recrystallization. Delivers >99.9% purity with reduced solvent waste for reliable API supply chains.
Patent CN1942460A enables efficient one-pot taxane semi-synthesis reducing steps and costs for reliable API intermediate supply chains globally.
Advanced synthesis of bendamustine key intermediates via patent CN102558069B. Offers superior purity, safety, and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN103102395A reveals a hybrid solid-phase and liquid-phase oxidation method for high-purity Desmopressin Acetate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel chromatography and crystallization method ensures high-purity Ambroxol HCl. Reduces toxic solvents and enhances supply chain stability for global pharmaceutical manufacturing.
Patent CN101628927A details a stereoselective route for Gemcitabine. Discover cost reduction in pharmaceutical manufacturing and high-purity oncology intermediates.
Patent CN112939971A discloses pyrido[2,3-d]pyrimidin-7-one derivatives as potent NEDD8 inhibitors, offering new routes for cost-effective API manufacturing and supply chain stability.
Patent CN108047230B reveals a novel acridine salt photocatalytic route for Ponatinib. Discover cost-effective, high-purity API manufacturing solutions.
Patent CN110317182B reveals a novel Cariprazine preparation method. Achieve higher yields and reduced genotoxic impurities for reliable API supply chains.
Advanced patent-based synthesis for Rucaparib intermediates. Enhanced yield, reduced toxicity, and scalable supply chain solutions for global pharmaceutical procurement.